Indeed, the observations that inhibition of TG2 by siRNA, small-molecule inhibitors or antisense RNA could render cancer cells sensitive to chemotherapeutic drugs and inhibit their invasiveness both in vitro and in animal models [13,14,17,24] strongly support such a contention. The gene discussed is TGM2; the disease is cancer.